← TANDEM DIABETES CARE INC
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $84.2m |
$107.6m
+27.72%
|
$183.9m
+70.88%
|
$362.3m
+97.05%
|
$498.8m
+37.68%
|
$702.8m
+40.89%
|
$801.2m
+14.00%
|
$747.7m
-6.68%
|
$940.2m
+25.74%
|
$1.0b
+7.93%
|
$1.0b
+2.63%
|
|
| Cost of Revenue | $60.7m |
$63.5m
+4.70%
|
$94.0m
+48.08%
|
$168.1m
+78.74%
|
$238.3m
+41.77%
|
$326.6m
+37.04%
|
$388.2m
+18.88%
|
$380.0m
-2.11%
|
$450.6m
+18.58%
|
$468.7m
+4.02%
|
$458.1m
-2.27%
|
|
| Gross Profit | $23.6m |
$44.1m
+86.90%
|
$89.8m
+103.71%
|
$194.2m
+116.22%
|
$260.5m
+34.14%
|
$376.2m
+44.41%
|
$413.0m
+9.77%
|
$367.7m
-10.97%
|
$489.6m
+33.15%
|
$546.0m
+11.53%
|
$583.3m
+6.83%
|
|
| Research and Development Expense | $18.8m | $20.7m | $29.2m | $45.2m | $63.6m | $92.1m | — | — | — | — | $187.7m | |
| Selling, General and Administrative Expense | $82.8m | $86.4m | $105.2m | $165.7m | $204.9m | $261.5m | $335.7m | $352.5m | $389.8m | $445.0m | $441.4m | |
| Amortization of Intangible Assets | $300k | $300k | $300k | $300k | $1.2m | $2.2m | $2.0m | $1.9m | $1.9m | $2.5m | — | |
| Operating Expenses | $101.6m | $107.0m | $134.5m | $210.9m | $268.5m | $353.6m | $505.8m | $600.9m | $588.7m | $733.3m | $629.1m | |
| Operating Income (Loss) | ($78.1m) |
($62.9m)
+19.36%
|
($44.6m)
+29.09%
|
($16.7m)
+62.53%
|
($8.0m)
+52.42%
|
$22.7m
+384.69%
|
($92.8m)
-509.87%
|
($233.2m)
-151.20%
|
($99.1m)
+57.50%
|
($187.3m)
-88.91%
|
($45.8m)
+75.54%
|
|
| Other Nonoperating Income (Expense) | ($5.4m) | ($10.1m) | ($77.9m) | ($7.9m) | ($28.3m) | ($6.8m) | ($4k) | $13.0m | $7.3m | ($13.0m) | — | |
| Interest Expense (non-operating) | — | — | — | — | — | — | — | — | $7.4m | $7.9m | $6.9m | |
| Income (Loss) from Equity Method Investments | — | — | — | — | — | — | $0 | $0 | ($2.1m) | ($14.2m) | — | |
| Interest and Other Income | $296k | $239k | $1.5m | $3.3m | $1.6m | $674k | $6.1m | $22.9m | $18.0m | — | — | |
| Income (Loss) from Continuing Operations before Income Taxes, Domestic | $83.5m | $73.0m | ($122.0m) | $24.9m | ($36.7m) | $15.2m | ($94.0m) | ($135.4m) | ($78.2m) | ($227.0m) | ($61.0m) | |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | ($83.5m) | ($73.0m) | ($122.6m) | ($24.6m) | ($36.3m) | $15.9m | ($92.9m) | ($220.3m) | ($91.9m) | ($200.3m) | ($61.0m) | |
| Current Income Tax Expense (Benefit) | $15k | $8k | $51k | $174k | $226k | $335k | $1.7m | $2.4m | $4.2m | $4.4m | $2.3m | |
| Income Tax Expense (Benefit) | ($15k) | $8k | $51k | $149k | ($1.9m) | $335k | $1.7m | $2.4m | $4.2m | $4.4m | $2.3m | |
| Net Income (Loss) Attributable to Parent | ($83.4m) |
($73.0m)
+12.48%
|
($122.6m)
-67.88%
|
($24.8m)
+79.81%
|
($34.4m)
-38.90%
|
$15.6m
+145.27%
|
($94.6m)
-707.70%
|
($222.6m)
-135.33%
|
($96.0m)
+56.86%
|
($204.7m)
-113.18%
|
($63.3m)
+69.07%
|
|
| Earnings Per Share, Basic | — | — | — | — | — | $0.25 | ($1.47) | ($3.43) | ($1.47) | ($3.04) | ($0.90) | |
| Earnings Per Share, Diluted | — | — | — | — | — | $0.24 | ($1.47) | ($3.43) | ($1.47) | ($3.04) | ($0.90) | |
| Weighted Average Number of Shares Outstanding, Basic | — | — | — | — | — | 63.0m | 64.1m | 65.0m | 65.5m | 67.3m | 68.3m | |
| Weighted Average Number of Shares Outstanding, Diluted | — | — | — | — | — | 64.3m | 64.1m | 65.0m | 65.5m | 67.3m | 68.3m |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.